I agree that this site is using cookies. You can find further informations here.
X
Shumel, B.
75  results:
Search for persons X
?
1

Efficacy and safety of dupilumab treatment with concomitant..:

Paller, A.S. ; Pinter, A. ; Lee, L. Wine...
Revue Française d'Allergologie.  63 (2023)  3 - p. 103411 , 2023
Link: https://doi.org/10.1016/..
 
?
2

POSA13 Dupilumab Treatment Reduces Hospitalizations in Adul..:

Silverberg, J ; Rubini, N ; Pires, MC...
Value in Health.  25 (2022)  1 - p. S20 , 2022
Link: https://doi.org/10.1016/..
 
?
3

IGAxBSA composite for assessing disease severity and respon..:

Paller, A.S. ; Tan, J.K.L. ; Bagel, J....
British Journal of Dermatology.  186 (2022)  3 - p. 496-507 , 2022
Link: https://doi.org/10.1111/..
 
?
4

Dupilumab safety and efficacy up to 52 weeks in adult and a..:

Dellon, E.S. ; Rothenberg, M.E. ; Collins, M.H....
Revue Française d'Allergologie.  62 (2022)  3 - p. 372 , 2022
Link: https://doi.org/10.1016/..
 
?
5

Un traitement par le dupilumab d'une durée allant jusqu'à 3..:

Blauvelt, A. ; Hussain, I. ; Beazley, B...
Annales de Dermatologie et de Vénéréologie.  147 (2020)  12 - p. A361-A362 , 2020
Link: https://doi.org/10.1016/..
 
?
6

Dupilumab provides rapid and sustained improvement in SCORA..:

Barbarot, S. ; Wollenberg, A. ; Silverberg, J. I....
Journal of Dermatological Treatment.  33 (2020)  1 - p. 266-277 , 2020
Link: https://doi.org/10.1080/..
 
?
7

Response to R. Waldmanet al.: 'Does IL‐4 inhibition play a ..:

Ardeleanu, M. ; Shumel, B. ; Rossi, A.B..
British Journal of Dermatology.  182 (2020)  5 - p. 1310-1312 , 2020
Link: https://doi.org/10.1111/..
 
?
8

评估接受 Dupilumab 治疗的中度至重度特应性皮炎患者进行常规安全性检测的必要性:

Wollenberg, A. ; Beck, L.A. ; Blauvelt, A....
British Journal of Dermatology.  182 (2020)  6 - p. , 2020
Link: https://doi.org/10.1111/..
 
?
9

Assessing the need for routine safety testing for patients ..:

Wollenberg, A ; Beck, L.A. ; Blauvelt, A....
British Journal of Dermatology.  182 (2020)  6 - p. , 2020
Link: https://doi.org/10.1111/..
 
?
10

Laboratory safety of dupilumab in moderate-to-severe atopic..:

Wollenberg, A. ; Beck, L.A. ; Blauvelt, A....
British Journal of Dermatology.  182 (2020)  5 - p. 1120-1135 , 2020
Link: https://doi.org/10.1111/..
 
?
11

Efficacité et sécurité du dupilumab chez des patients adult..:

Bouaziz, J.-D. ; Ogg, G. ; de Bruin-Weller, M....
Annales de Dermatologie et de Vénéréologie.  146 (2019)  12 - p. A341-A342 , 2019
Link: https://doi.org/10.1016/..
 
?
12

Conjunctivitis in dupilumab clinical trials:

Akinlade, B. ; Guttman‐Yassky, E. ; Bruin‐Weller, M....
British Journal of Dermatology.  181 (2019)  3 - p. , 2019
Link: https://doi.org/10.1111/..
 
?
13

Effets du dupilumab sur les résultats du SCORAD dans la der..:

Wollenberg, A. ; Szepietowski, J.C. ; Tsianakas, A....
Annales de Dermatologie et de Vénéréologie.  146 (2019)  12 - p. A339 , 2019
Link: https://doi.org/10.1016/..
 
?
14

Conjunctivitis in dupilumab clinical trials:

Akinlade, B. ; Guttman‐Yassky, E. ; Bruin‐Weller, M....
British Journal of Dermatology.  181 (2019)  3 - p. 459-473 , 2019
Link: https://doi.org/10.1111/..
 
?
15

Improvement of atopic dermatitis with dupilumab occurs equa..:

Blauvelt, A. ; Rosmarin, D. ; Bieber, T....
British Journal of Dermatology.  181 (2019)  1 - p. 196-197 , 2019
Link: https://doi.org/10.1111/..
 
1-15